Loading...
Printed on 7/21/2026
For informational purposes only. This is not medical advice.
ADCS-ADL is a structured caregiver/informant assessment of daily functioning often used in dementia clinics and Alzheimer disease trials. Totals are interpreted longitudinally, where lower scores over time generally indicate worsening functional dependence.
Formula: ADCS-ADL total is a summed functional score (commonly represented on a 0-78 range), with higher values indicating better function.
Save your results with a free account
Keep a history of calculations, favorite tools, and access your dashboard anytime.
ADCS-ADL is completed by a caregiver who has observed the patient's daily activities over the past 4 weeks. The informant should have sufficient contact to reliably judge performance — ideally someone living with or providing daily care to the patient.
The caregiver rates 23 basic and instrumental ADL items including: eating, dressing, bathing, toileting, walking, using the telephone, shopping, housekeeping, managing finances, using household appliances, preparing food, medication management, and other complex daily tasks. Each item is scored based on the level of performance and assistance required.
Total ADCS-ADL scores range from 0 to 78, where higher scores indicate better preserved functional independence. Serial scores are more informative than single measurements — declining scores document progressive functional impairment, while stable or improving scores may indicate treatment efficacy.
Clinical researchers and pharmaceutical investigators
ADCS-ADL was specifically designed as a functional outcome measure for Alzheimer's disease treatment trials and is used as a primary or co-primary endpoint in regulatory submission studies for AD therapeutics.
Geriatricians, neurologists, and dementia nurses
Serial ADCS-ADL scores at clinic visits provide objective documentation of functional trajectory, supporting treatment decision-making and goals-of-care discussions with patients and families.
Social workers and aged care coordinators
Low ADCS-ADL scores quantify functional dependence and caregiver burden, informing decisions about respite services, home care package level, and readiness for residential care transition.
Neuropsychologists and cognitive researchers
ADCS-ADL scores correlate with cognitive test performance across dementia stages. Comparing functional decline rates to cognitive decline rates provides insight into the specific ADL domains most affected by cognitive deterioration.
Prescribing physicians and dementia pharmacists
For patients on cholinesterase inhibitors or other AD-modifying therapies, ADCS-ADL tracks whether functional performance is stabilising, slowing its rate of decline, or continuing to deteriorate despite treatment.
ADCS-ADL measures what the patient actually does in daily life, not what they could do if prompted or assisted. If a patient used to pay bills but no longer does because a family member does it for them, this should be scored as impaired regardless of theoretical capability.
Some ADCS-ADL items (e.g., managing finances, using appliances) may never have been performed by certain patients due to lifelong patterns rather than dementia. Document premorbid ADL patterns to distinguish true functional decline from never-performed activities.
ADCS-ADL is scored in the direction of preserved function: 78 = fully independent across all activities, 0 = complete dependence. Ensure clinicians and data entry staff understand this directionality to avoid score interpretation errors.
Single ADCS-ADL scores have limited interpretive value without comparison to a prior baseline. Establish baseline early in the clinical relationship and measure at 6–12-month intervals to capture meaningful trajectory.
ADCS-ADL includes both basic ADLs (eating, bathing, dressing, toileting, walking) and instrumental ADLs (finances, shopping, appliances). Tracking subscores separately reveals whether impairment is progressing from higher-order instrumental tasks toward more fundamental self-care.
If multiple carers provide care across different domains (e.g., one family member assists with medications, another with finances), identify the most knowledgeable informant for each domain or use the primary daily carer for the whole assessment.
The standard ADCS-ADL has ceiling effects in mild dementia. The ADCS-ADL-MCI (23-item version designed for MCI and mild AD) includes more complex instrumental tasks and is more sensitive for early functional change in clinical trial settings.
Functional decline (ADCS-ADL decline) interpreted alongside cognitive decline (MMSE or ADAS-Cog) and behavioural symptoms (NPI-Q) provides a complete picture of disease burden. Functional decline without proportionate cognitive change may suggest comorbid depression, pain, or deconditioning.
ADCS-ADL is a widely used functional endpoint in Alzheimer disease research and longitudinal clinical follow-up.
Higher ADCS-ADL totals indicate better retained daily function; declining serial scores suggest progressive functional impairment.
Use when caregiver-informed functional tracking is needed in Alzheimer disease or related dementia follow-up.
Scale versions vary by study/context and scoring depends on informant reliability and patient-caregiver interaction level.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
April 21, 2026 · v1.0.0
Added ADCS-ADL trust metadata and first changelog entry for versioned maintenance.
Assess independence in six basic activities of daily living with the Katz ADL Index. Scores range from 0 (dependent) to 6 (fully independent).
OpenGeriatricsAssess independence in higher-level daily tasks using the Lawton IADL scale (score 0-8).
OpenGeriatricsAssess instrumental daily-function impairment with the 10-item Pfeffer FAQ (0-30).
OpenGeriatricsA brief informant-rated cognitive-functional staging scale used to estimate dementia severity burden.
Open